M. Amorꢁn, J. R. Granja et al.
(amide III), 1624 (amide I), 1525 cmÀ1 (amide II); MS (ESI): m/z (%):
997 (100) [M+Na]+, 975 (43) [M+H]+; HRMS (ESI): m/z: calcd for
C56H75N7NaO8: 996.5569; found: 996.5576.
NHLys), 7.55 (brs, 0.6H; Ar2-DPPBA), 7.44 (brs, 0.35H; Ar2-DPPBA), 7.36–7.10
(m, 22H; ArPhe, Ar2ÀDPPBA), 6.91 (s, 1H; Ar2ÀDPPBA), 6.48 (s, 0.35H;
NHwLys), 6.05 (s, 0.30H; NHwLys), 5.30 (m, 2H; HaPhe), 5.11 (m, 0.60H;
HaLys), 5.04 (m, 0.40H; HaLys), 4.54 (m, 3H; HgAch), 3.19–2.73 (m, 9H;
HaAch, HbPhe, HdLys), 2.99 (s, 3H; Me-N), 2.55, 2.53, 2.52, 2.51, 2.50,
2.48 ppm (6 s, 6H; Me-N); 31P NMR (121 MHz, CDCl3, 258C): d=
À11.4 ppm; FTIR (293 K, CaF2 Pellet): n˜ =3303 (amide A), 3002, 2932,
2861, 1657 (amida III), 1624 (amide I), 1528 cmÀ1 (amide II); MS (ESI):
c-[l-Ser
ACHTUNGTRENNUNG
tion of
56 mmol) in Pd(OH)2 (10 mg, 20% wt.) in EtOH (630 mL) was stirred at
RT for 5 h under a hydrogen atmosphere (balloon pressure). The result-
ing mixture was filtered through a Celite pad, the residue was washed
with ethanol, and the combined filtrates and washings were concentrated
under reduced pressure. The resulting material was dissolved in CH2Cl2
(270 mL) and treated with 2-(diphenylphosphino)benzoic acid (2-DPPBA,
12.6 mg, 41 mmol), HOBt (8.4 mg, 60 mmol), EDC·HCl (12 mg, 60 mmol),
and DMAP (7.6 mg, 60 mmol). After 3 h the solvent was removed under
reduced pressure. The residue was purified by flash chromatography (2–
6% MeOH/CH2Cl2) to afford 31 mg of CP4 as a white solid (69%, Rf =
m/z (%): 1151 (6) [M+Na]+, 1129 (100) [M+H]+, 565 (92) [M+H]2+
;
HRMS (ESI): m/z: calcd for C67H83N7O7P: 1128.6086; found: 1128.6061.
c-[l-Prg-d-MeN-g-Acp-(l-Leu-d-MeN-g-Acp-)2] (CP7): The mentioned
cyclic peptide was prepared from Boc-(l-Leu-d-MeN-g-Acp-)2l-Prg-
d-MeN-g-Acp-OFm (188 mg, 0.19 mmol) by following a similar procedure
described for c-[l-Ser(Bn)-d-MeN-g-Ach-(l-Phe-d-MeN-g-Ach-)2] to
afford, after purification by flash chromatography (2–7% MeOH/
CH2Cl2), 110 mg of CP7 as a white solid (84%, Rf =0.6 (5% MeOH/
CH2Cl2)). 1H NMR (500 MHz, CDCl3, 258C, TMS): d=8.35 (d,
1
0.50 (5% MeOH/CH2Cl2)). H NMR (500 MHz, CDCl3, 258C, TMS): d=
8.76 (d, 3J(H,H)=9.2 Hz, 0.40H; NHPhe), 8.73 (d, 3J
ACHTUNGTRENNUNG ACHTUNGTRENNUNG
3J
NHPrg), 8.22 (d, 3J
3J(H,H)=8.3 Hz, 0.50H; NHLeu), 5.35 (q, 3J
ACHTUNGTRENNUNG
N
ACHTUNGTRENNUNG
0.30H; NHPhe), 8.69 (d, 3J
3J
ACHTUNGTRENNUNG
E
,
N
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
5.17 (m, 2H; HaLeu), 4.94–4.69 (m, 3H; HgAcp), 3.10 (s, 3H; Me-N), 3.07
(s, 6H; Me-N), 2.92 ppm (m, 3H; HaAcp); FTIR (293 K, CaF2 Pellet): n˜ =
3300 (amide A), 2956, 1672 (amide III), 1618 (amide I), 1533 cmÀ1 (amide
II); MS (ESI): m/z (%): 719 (78) [M+Na]+, 698 (100) [M+H]+; HRMS
(ESI): m/z: calcd for C38H61N6O6: 697.4647; found: 697.4637.
AHCTUNGTRENNUNG
(brs, 1H; Ar2-DPPBA), 7.22 (m, 22H; ArPhe, Ar2-DPPBA), 6.89 (brs, 1H;
Ar2-DPPBA), 5.51 (brs, 1H; HaSer), 5.33 (m, 2H; HaPhe), 4.53 (m, 3.75H; 3
HgAch, 0.75 HbSer), 4.38 (dd, 3J
ACHTUNGTRENNUNG
(m, 0.75H; HbSer), 4.11 (dd, 3J
ACHTUNGTRENNUNG
c-[l-Prg(4-methoxyphenyl)-d-MeN-g-Acp-(l-Leu-d-MeN-g-Acp-)2] (CP8):
In a screw-cap sealed tube a mixture of CP7 (5.0 mg, 6.95 nmol), 4-iodoa-
nisole (3.4 mg, 14.5 nmol), AuCl·SMe2 (2.1 mg, 71.3 nmol), CP6 (8.1 mg,
71.9 nmol), and Et3N (6 mL) were dissolved in CHCl3 (2.5 mL) and [Pd2-
2.97 (2 s, 2.30H; Me-N), 2.90 (s, 0.70H; Me-N), 2.54, 2.53, 2.51, 2.50,
2.49 ppm (5 s, 6H; Me-N); 31P NMR (121 MHz, CDCl3, 258C): d=
À6.0 ppm; FTIR (293 K, CaF2 Pellet): n˜ =3307 (amide A), 3001, 2931,
2860, 1718, 1670 (amide III), 1626 (amide I), 1523 cmÀ1 (amide II); MS
(ESI): m/z (%): 1088 (100) [M+H]+; HRMS (ESI): m/z: calcd for
C64H76N6O8P: 1087.5457; found: 1087.5453.
AHCTUNTGREGUN(NN dba)3]·CHCl3 (1.2 mol%, 0.76 mg, 0.083 nmol) was added. The tube was
sealed and heated at 408C for 24 h. After cooling down, the mixture was
purified by HPLC (Rt =15.0 min, 5–15% MeOH/CH2Cl2, Phenomenex,
5 m, 250ꢅ10.00 mm, 5 micron) to afford 2 mg of CP8 as a yellow oil
c-[l-SerACHTUNGTRENNUNG
(4-DPPBA)-d-MeN-g-Ach-(l-Phe-d-MeN-g-Ach-)2] (CP5): Pre-
pared from c-[l-Ser(Bn)-d-MeN-g-Ach-(l-Phe-d-MeN-g-Ach-)2] (21.7 mg,
24 mmol) in the same way as CP4 to yield, after HPLC purification (Rt =
(35%). 1H NMR (500 MHz, CDCl3, 258C, TMS): d=8.38 (d, 3J
ACHTUNGTRENNUNG
6.4 Hz, 1H; NHPrg), 8.23 (d, 3J
Ar), 6.80 (d, 3J
ACHTUNGTRENNUNG
17.3 min, 1–15% MeOH/CH2Cl2, Phenomenex, 5 m, 250ꢅ10.0 mm,
5
N
ACHTUNGTRENNUNG
micron), 18.5 mg of CP5 as a white solid (71%, Rf =0.50 (5% MeOH/
CH2Cl2)). 1H NMR (500 MHz, CDCl3, 258C, TMS): d=8.76 (d,
HaPrg), 5.17 (s, 2H; HaLeu), 4.95–4.72 (m, 3H; HgAcp), 3.79 (s, 3H; Me-
O), 3.13 (s, 3H; Me-N), 3.08 (s, 6H; Me-N), 2.95 ppm (m, 3H; HaAcp);
FTIR (293 K, CaF2 Pellet): n˜ =3300 (amide A), 2957, 2872, 1672 (amide
III), 1622 (amide I), 1531 cmÀ1 (amide II); MS (ESI): m/z (%): 1607 (10)
[M+H]2+, 826 (54) [M+Na]+, 804 (100) [M+H]+; HRMS (ESI): m/z:
calcd for C45H67N6O7: 803.5066; found: 803.5078.
3J
NHPhe), 8.68 (d, 3J
8.6 Hz, 0.35H; NHPhe), 8.36 (d, 3J
3J(H,H)=7.9 Hz, 0.30H; NHSer), 8.31 (d, 3J
NHSer), 7.83 (d, 3J
(H,H)=7.7 Hz, 2H; CH-Ar2-DPPBA), 7.25 (m, 22H;
ACHTUNGTRENNUNG ACHTUNGTRENNUNG
(H,H)=9.1 Hz, 0.60H; NHPhe), 8.72 (d, 3J
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
ACHTUNGTRENNUNG
c-[l-Prg[Au]-d-MeN-g-Acp-(l-Leu-d-MeN-g-Acp-)2] (CP7[Au])n: A solu-
tion of CP7 (8.0 mg, 9.96 nmol) and Et3N (10 mL, 71.9 nmol) in THF
(750 mL) was added to a solution of AuCl·SMe2 (3.4 mg, 11.54 nmol) in
THF (750 mL) and MeOH (560 mL). After having been stirred at RT for
30 min the solid was isolated by filtration, washed successively with THF,
MeOH, and Et2O to afford, after high vacuum drying, 8.1 mg of
CH-ArPhe, CH-Ar2-DPPBA), 5.61 (m, 1H; HaSer), 5.31 (m, 2H; HaPhe), 4.70–
4.24 (m, 5H; HgAch, HbSer), 3.13–2.75 (m, 7H; HbPhe, HaAch), 3.10, 3.09,
3.08 (3s, 3H; Me-N), 2.53, 2.52, 2.51, 2.50 ppm (4s, 6H; Me-N);
31P NMR (121 MHz, CDCl3, 258C): d=À7.5 ppm; FTIR (293 K, CaF2
Pellet): n˜ =3307 (amide A), 2929, 2858, 1730, 1670 (amide III), 1624
(amide I), 1522 cmÀ1 (amide II); MS (ESI): m/z (%): 1110 (64) [M+Na]+,
1088 (79) [M+H]+, 544 (100) [M+H]2+; HRMS (ESI): m/z: calcd for
C64H76N6O8P: 1087.5457; found: 1087.5449.
AHCTUNGTREG(NNNU CP7[Au])n (79%). The peptide was stored in the refrigerator and pro-
tected from light and used without further characterization.[18]
c-[l-LysACHTUNGTRENNUNG
(2-DPPBA)-l-MeN-g-Ach-(l-Phe-d-MeN-g-Ach-)2] (CP6): A solu-
D(S)4–7[Au]: Procedure A: Peptide CP4 (4.9 mg, 4.5 nmol) was dis-
solved in CDCl3 (500 mL) in a NMR tube and portions (0.25, 0.50, 0.75,
tion of c-[l-Lys(Z)-l-MeN-g-Ach-(l-Phe-d-MeN-g-Ach-)2] (33.3 mg,
34 mmol) in Pd/C (6.7 mg, 10% in wt.) in MeOH (2.2 mL) was stirred at
RT for 5 h under hydrogen atmosphere (balloon pressure). The resulting
mixture was filtered through a Celite pad, the residue was washed with
methanol, and the combined filtrates and washings were concentrated
under reduced pressure. The resulting material was dissolved in CH2Cl2
(340 mL) and treated with 2-DPPBA (10.5 mg, 34 mmol) and HATU
(14.2 mg, 37 mmol), followed by the dropwise addition of DIEA (35 mL,
0.204 mmol). After 3 h the solvent was removed under reduced pressure.
The crude was purified by flash chromatography (0–6% MeOH/CH2Cl2)
to afford 19.0 mg of CP6 as a white solid (50%, Rf =0.50 (5% MeOH/
and 1.0 equiv) of
dimer formation. 1H NMR (500 MHz, CDCl3, 258C, TMS): d=8.73 (d,
3J(H,H)=9.6 Hz, 1H; NHLeu), 8.65 (d, 3J
(H,H)=9.4 Hz, 1H; NHLeu),
8.46 (d, 3J(H,H)=9.5 Hz, 1H; NHSer), 8.43 (d, 3J
(H,H)=9.5 Hz, 1H;
NHPhe), 8.42 (d, 3J(H,H)=9.4 Hz, 1H; NHPhe), 8.04 (d, 3J
(H,H)=6.3 Hz,
1H; NHPrg), 7.82 (m, 1H; Ar2-DPPBA), 7.55–7.44 (m, 6H; Ar), 7.43–7.34
(m, 6H; Ar), 7.29–7.11 (m, 10H; ArPhe), 6.86 (dd, 3J
(H,H)=10.3, 8.3 Hz,
ACHTUNGTRNE(NUNG CP7[Au])n (4.5 mg, 4.5 nmol) were added for hetero-
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
1H; Ar2-DPPBA), 5.50 (m, 1H; HaSer), 5.24 (m, 2H; HaLeu, HaPhe), 5.18 (m,
2H; HaLeu, HaPhe), 5.00 (m, 3H; HgAcp), 4.86 (brs, 1H; HaPrg), 4.71 (dd,
3
3J
C
G
1
3
CH2Cl2). H NMR (500 MHz, CDCl3, 258C, TMS): d=8.77 (d, J
9.4 Hz, 0.35H; NHPhe), 8.75 (d, 3J
(H,H)=9.4 Hz, 0.35H; NHPhe), 8.69 (d,
3J(H,H)=8.8 Hz, 0.35H; NHPhe), 8.67 (d, 3J
(H,H)=8.8 Hz, 0.35H;
NHPhe), 8.61 (d, 3J(H,H)=8.4 Hz, 0.35H; NHPhe), 8.59 (d, 3J
(H,H)=
8.4 Hz, 0.35H; NHPhe), 8.45 (d, 3J
(H,H)=9.3 Hz, 0.30H; NHLys), 8.40 (d,
3J(H,H)=9.6 Hz, 0.30H; NHLys), 8.26 (d, 3J
(H,H)=9.4 Hz, 0.36H;
ACHTUNGTRNE(NUNG H,H)=
4.37 (m, 3H; HgAch), 3.25 (m, 2H; HbPrg, HaAcp), 3.11 (s, 3H; Me-N),
G
3.09 (s, 3H; Me-N), 2.98 (s, 3H; Me-N), 2.98 (s, 3H; Me-N), 2.81 (d,
E
R
3J
ACTHNGUTREN(NUG H,H)=17.0 Hz, 1H; HbPrg), 2.72 (m, 2H; HaAcp, HaAch), 2.58 (s, 3H;
G
A
Me-N), 2.56 (s, 3H; Me-N), 2.72 (m, 2H; HaAch), 2.34–2.03 (m, 2H;
HaAcp), 0.90 ppm (overlapped doublets, 12H; MeLeu); 31P NMR
(121 MHz, CDCl3, 258C): d=40.9 ppm; FTIR (293 K, CHCl3): n˜ =3302
AHCTUNGTRENNUNG
R
ACHTUNGTRENNUNG
4832
ꢄ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2013, 19, 4826 – 4834